Abstract
Recently, increasing attention has been paid to the correlation between the expression of downstream of kinase 7 (DOK7) and the occurrence and development of various tumors. In this study, we clarified the effects of DOK7 in breast cancer. First, we showed that DOK7 expression was obviously reduced in the breast cancer tissues and lower levels of DOK7 linked to more aggressive behaviors and worse prognosis of patients. Furthermore, DOK7 expression of various breast cancer cell lines was lower than that of human noncancerous MCF-10A cells. Overexpression of DOK7 inhibited proliferation, migration, and invasion, while silencing DOK7 expression promoted the malignancy of breast cancer. In addition, overexpression of DOK7 suppressed tumor proliferation and lung metastasis in animal models. Finally, to investigate the possible signaling mechanism, we first found that the level of p-AKT protein was extremely downregulated and the level of PTEN protein was remarkably upregulated after overexpressing DOK7 in breast cancer cells. Repression of PTEN expression using PTEN siRNA or SF1670 (PTEN inhibitor) rescued the tumor-inhibiting effect induced by DOK7 overexpression, suggesting that DOK7 inhibits proliferation, migration, and invasion of breast cancer cells though the PI3K/PTEN/AKT pathway. These results suggest that the downregulation of DOK7 may become a novel breast cancer therapeutic target.
Highlights
Breast cancer is the most frequently occurring malignancy and has a high mortality rate in cancer patients among worldwide [1]
We demonstrated that downstream of kinase 7 (DOK7) inhibits proliferation, migration, and invasion via the PI3K/PTEN/AKT pathway in breast cancer cells
In matched breast tissue pairs obtained from 68 breast cancers (Table 1), DOK7 expression was obviously decreased in tumors (Figure 1(a))
Summary
Breast cancer is the most frequently occurring malignancy and has a high mortality rate in cancer patients among worldwide [1]. A recent study has showed that the low level of DOK7 was responsible for poor prognosis in lung cancer patients and DOK7 played an important role on cell growth, migration, and invasion [13]. Another study showed that silencing the expression of DOK7 significantly inhibited the development of glioma both in cells and in animal models [16]. We displayed that the expression of DOK7 was remarkably reduced in clinical breast cancer tissues and the low levels of DOK7 were related to the bad Journal of Oncology clinical outcomes and prognosis in breast cancer patients. The overexpression of DOK7 inhibits proliferation, invasion, and migration of breast cancer. We demonstrated that DOK7 inhibits proliferation, migration, and invasion via the PI3K/PTEN/AKT pathway in breast cancer cells
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
